awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35198538-A7D59AC0-3411-4EB1-925A-FAD297746BBC
Q35198538-A7D59AC0-3411-4EB1-925A-FAD297746BBC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35198538-A7D59AC0-3411-4EB1-925A-FAD297746BBC
A phase 2 multi-center, open-label, switch-over trial to evaluate the safety and efficacy of Abcertin® in patients with type 1 Gaucher disease.
P2860
Q35198538-A7D59AC0-3411-4EB1-925A-FAD297746BBC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35198538-A7D59AC0-3411-4EB1-925A-FAD297746BBC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be27da647b70eb308e2648538b9d6a8a24bfc4d8
P2860
The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement